Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and NewAmsterdam Pharma Company N.V. (NAMS)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
Compare Returns for S&P 500 and NAMS | ||
---|---|---|
S&P 500 | NAMS | |
Start Date | Dec-01-2022 | Dec-30-2022 |
Start Price | $2,476.46 | $10.90 |
End Date | May-01-2024 | May-17-2024 |
End Price | $5,018.39 | $20.09 |
Number Monthly Prices | 18 | 18 |
Min Date | Mar-01-2023 | Oct-31-2023 |
Min Price | $4,099.01 | $9.00 |
Max Date | Apr-01-2024 | Mar-28-2024 |
Max Price | $5,243.77 | $23.65 |
Total Return | 22.11% | 84.31% |
Annualized Return | 14.25% | 50.33% |
Current Value of $1,000 Purchase | $1,221 | $1,843 |
Number Returns | 153 | 153 |
Average Return | 9.75% | 33.27% |
Minimum Return | -5.90% | -36.75% |
Maximum Return | 27.93% | 162.78% |
Number Profitable Returns | 139 | 90 |
Percent Profitable Returns | 90.85% | 58.82% |
Number Unprofitable Returns | 14 | 63 |
Percent Unprofitable Returns | 9.15% | 41.18% |
Profitable to Unprofitable Returns Ratio | 9.93 | 1.43 |
NAMS Performance Table and Chart
NAMS Dollar-cost Average
NAMS Trendline Chart
NAMS Moving Average Chart
NAMS Stock Return Map - See Patterns of Gains and Losses
NAMS Stock Returns/Purchase Dates